Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Parharn
    Member
    • Jul 2013
    • 84

    iGenome S. pombe builds

    Hi,
    I am wondering what are "builds" in iGenomes data base.
    I work on S.pombe. I don't know which build to use for my analysis. EF1 or EF2?

    The link to the webpage is here: http://support.illumina.com/sequenci...e/igenome.ilmn

    Thanks,
    Parham
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    EF2 should be a later genome build than EF1 (following the convention). So you would probably want to use EF2.

    Ensembl appears to have dropped EF* designations for the yeast genomes with the latest pombe genome now called "ASM294v2": http://fungi.ensembl.org/Schizosacch...be/Info/Index/

    Comment

    • Parharn
      Member
      • Jul 2013
      • 84

      #3
      Thanks, but the EF2 contains all the index files for bowtie and stuff. The ASM294v2 seems that contains only the reference files.

      Comment

      • GenoMax
        Senior Member
        • Feb 2008
        • 7142

        #4
        EF2 version from iGenomes would be convenient to use since it is cleaned up (names etc) and has all the indexes/annotations pre-built. For most applications that would be just fine (unless you are doing something that requires the latest genome build. Then you would have to download the genome and build the index yourself).

        Comment

        • Parharn
          Member
          • Jul 2013
          • 84

          #5
          Got it, thanks GenoMax!

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          21 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          19 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          26 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          38 views
          0 reactions
          Last Post SEQadmin2  
          Working...